Prospective of healthcare professionals regarding pharmacogenomics

IF 0.7 Q4 PHARMACOLOGY & PHARMACY Egyptian Pharmaceutical Journal Pub Date : 2023-04-01 DOI:10.4103/epj.epj_175_22
Anuradha T Deshkar, Sonali B. Rode
{"title":"Prospective of healthcare professionals regarding pharmacogenomics","authors":"Anuradha T Deshkar, Sonali B. Rode","doi":"10.4103/epj.epj_175_22","DOIUrl":null,"url":null,"abstract":"Background and objective Pharmacogenomics is an emerging branch and its application in clinical practice will improve healthcare delivery in India. For the promotion and adaptation of pharmacogenomics, we need baseline data from healthcare professionals (HCPs). So, this study was planned to know the prospective of HCPs in India regarding pharmacogenomics. Patients and methods The printed copies of the pretested and validated, single-response or multiple-response self-administered questionnaire, were distributed to the HCPs. There was a total of 19 questions to access knowledge, attitude, and practices regarding pharmacogenomics. Data obtained were entered in Microsoft Excel 2013 spreadsheet for statistical analysis and percentages were calculated for concerned responses. Results Out of 134 responses, 126 responses were found to be eligible for analysis. Seventy-eight (61.9%) participants scored more than or equal to 5 to show above-average knowledge. Ninety (71.4%) participants showed a favorable attitude with a score of more than or equal to 3, while 91 (72.2%) participants scored more than or equal to 3 to show favorable practices regarding pharmacogenomics. Hundred and seven (84.9%) participants believed that pharmacogenomics will lead to more effective pharmacotherapy. Conclusion Participants showed above-average knowledge; favorable attitude, and practice behavior regarding pharmacogenomics. The survey indicates that conducting Information, Education, and Communication activities may help to increase awareness and knowledge, and to promote the adoption and utilization of pharmacogenomics in clinical practice, which will lead to better pharmacological treatment of disease with maximum efficacy and minimum side effects.","PeriodicalId":11568,"journal":{"name":"Egyptian Pharmaceutical Journal","volume":"22 1","pages":"259 - 264"},"PeriodicalIF":0.7000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/epj.epj_175_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective Pharmacogenomics is an emerging branch and its application in clinical practice will improve healthcare delivery in India. For the promotion and adaptation of pharmacogenomics, we need baseline data from healthcare professionals (HCPs). So, this study was planned to know the prospective of HCPs in India regarding pharmacogenomics. Patients and methods The printed copies of the pretested and validated, single-response or multiple-response self-administered questionnaire, were distributed to the HCPs. There was a total of 19 questions to access knowledge, attitude, and practices regarding pharmacogenomics. Data obtained were entered in Microsoft Excel 2013 spreadsheet for statistical analysis and percentages were calculated for concerned responses. Results Out of 134 responses, 126 responses were found to be eligible for analysis. Seventy-eight (61.9%) participants scored more than or equal to 5 to show above-average knowledge. Ninety (71.4%) participants showed a favorable attitude with a score of more than or equal to 3, while 91 (72.2%) participants scored more than or equal to 3 to show favorable practices regarding pharmacogenomics. Hundred and seven (84.9%) participants believed that pharmacogenomics will lead to more effective pharmacotherapy. Conclusion Participants showed above-average knowledge; favorable attitude, and practice behavior regarding pharmacogenomics. The survey indicates that conducting Information, Education, and Communication activities may help to increase awareness and knowledge, and to promote the adoption and utilization of pharmacogenomics in clinical practice, which will lead to better pharmacological treatment of disease with maximum efficacy and minimum side effects.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医疗保健专业人员对药物基因组学的展望
背景和目的药物基因组学是一个新兴的分支,其在临床实践中的应用将改善印度的医疗服务。为了促进和适应药物基因组学,我们需要来自医疗保健专业人员(HCP)的基线数据。因此,本研究旨在了解印度HCP在药物基因组学方面的前景。患者和方法将预先测试和验证的、单应答或多应答的自行管理问卷的打印副本分发给HCP。共有19个问题涉及药物基因组学的知识、态度和实践。将获得的数据输入Microsoft Excel 2013电子表格中进行统计分析,并计算相关回复的百分比。结果在134份回复中,126份回复符合分析条件。78名(61.9%)参与者的得分超过或等于5分,显示出高于平均水平的知识。90名(71.4%)参与者表现出良好的态度,得分大于或等于3分,而91名(72.2%)参与者得分大于或相等于3分,表现出在药物基因组学方面的良好实践。107名(84.9%)参与者认为药物基因组学将带来更有效的药物治疗。结论参与者的知识水平高于平均水平;良好的态度和实践行为。调查表明,开展信息、教育和交流活动可能有助于提高认识和知识,并促进药物基因组学在临床实践中的采用和利用,这将导致以最大疗效和最小副作用对疾病进行更好的药物治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Egyptian Pharmaceutical Journal
Egyptian Pharmaceutical Journal PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
37
期刊最新文献
Therapeutic effects of the Egyptian horned viper LAAO against hepatocellular carcinoma induced in rats Effect of different carbon sources on callus formation, pigment accumulation, and antiviral activity in cell cultures of Euphorbia milii Anticoagulant and antibacterial activities of polysaccharides fraction from Nostoc muscorum and Arthrospira platensis cultivated under abiotic stress conditions Stem cell mechanism of action in neuroplasticity after stroke Metallo β- lactamase producing pseudomonas aeruginosa: a worrisome situation to handle
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1